18,610 Shares in Chemours Company (The) (CC) Purchased by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. acquired a new position in Chemours Company (The) (NYSE:CC) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 18,610 shares of the specialty chemicals company’s stock, valued at approximately $942,000.

Several other large investors have also modified their holdings of the business. Acrospire Investment Management LLC grew its stake in shares of Chemours Company (The) by 3.4% in the 2nd quarter. Acrospire Investment Management LLC now owns 3,076 shares of the specialty chemicals company’s stock worth $117,000 after buying an additional 100 shares in the last quarter. Cypress Capital Management LLC boosted its stake in shares of Chemours Company (The) by 0.5% during the 2nd quarter. Cypress Capital Management LLC now owns 31,393 shares of the specialty chemicals company’s stock worth $1,190,000 after purchasing an additional 155 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Chemours Company (The) by 0.6% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 26,921 shares of the specialty chemicals company’s stock worth $1,021,000 after purchasing an additional 167 shares during the period. Commerce Bank boosted its stake in shares of Chemours Company (The) by 3.0% during the 2nd quarter. Commerce Bank now owns 7,158 shares of the specialty chemicals company’s stock worth $272,000 after purchasing an additional 206 shares during the period. Finally, World Asset Management Inc boosted its stake in shares of Chemours Company (The) by 4.0% during the 2nd quarter. World Asset Management Inc now owns 15,652 shares of the specialty chemicals company’s stock worth $594,000 after purchasing an additional 597 shares during the period. 73.23% of the stock is owned by institutional investors and hedge funds.

CC has been the subject of a number of recent analyst reports. Jefferies Group LLC lifted their price target on shares of Chemours Company (The) to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 3rd. Citigroup Inc. lifted their price target on shares of Chemours Company (The) from $45.00 to $59.00 and gave the stock a “buy” rating in a research note on Friday, August 4th. J P Morgan Chase & Co lifted their price target on shares of Chemours Company (The) to $55.00 and gave the stock an “overweight” rating in a research note on Friday, August 4th. UBS AG raised shares of Chemours Company (The) from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $36.00 to $50.00 in a research note on Monday, August 7th. Finally, Argus reaffirmed a “buy” rating and set a $55.00 price target (up from $50.00) on shares of Chemours Company (The) in a research note on Thursday, August 10th. One investment analyst has rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Chemours Company (The) currently has a consensus rating of “Buy” and a consensus price target of $53.89.

In other Chemours Company (The) news, SVP David C. Shelton sold 19,000 shares of the business’s stock in a transaction dated Thursday, October 5th. The shares were sold at an average price of $53.68, for a total value of $1,019,920.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider E Bryan Snell sold 13,000 shares of the business’s stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $49.35, for a total transaction of $641,550.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 76,520 shares of company stock valued at $4,008,293. 1.14% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “18,610 Shares in Chemours Company (The) (CC) Purchased by Crossmark Global Holdings Inc.” was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this report on another domain, it was stolen and republished in violation of U.S. and international copyright & trademark law. The original version of this report can be accessed at https://www.chaffeybreeze.com/2017/11/12/18610-shares-in-chemours-company-the-cc-purchased-by-crossmark-global-holdings-inc.html.

Shares of Chemours Company (CC) opened at $50.07 on Friday. The stock has a market cap of $9,271.11, a PE ratio of 17.76, a price-to-earnings-growth ratio of 0.89 and a beta of 3.59. The company has a debt-to-equity ratio of 5.07, a current ratio of 2.19 and a quick ratio of 1.63. Chemours Company has a 52-week low of $20.22 and a 52-week high of $58.08.

Chemours Company (The) (NYSE:CC) last released its quarterly earnings data on Thursday, November 2nd. The specialty chemicals company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.11. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Chemours Company (The) had a net margin of 4.86% and a return on equity of 116.80%. The firm’s quarterly revenue was up 13.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.61 EPS. equities research analysts anticipate that Chemours Company will post 3.65 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 15th. Shareholders of record on Monday, November 20th will be given a $0.03 dividend. The ex-dividend date of this dividend is Friday, November 17th. This represents a $0.12 annualized dividend and a yield of 0.24%. Chemours Company (The)’s dividend payout ratio (DPR) is 8.28%.

Chemours Company (The) Company Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemours Company (The) (NYSE:CC).

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply